AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01782872 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interscalene Block (ISB) - 0.1% Ropivacaine + additives
Description: Ultrasound-guided single-injection ISB: ropivacaine 0.1% + (clonidine \[100 mcg\] + dexamethasone \[4 mg\] + buprenorphine \[150 mcg\]); Intravenous: saline
Study NCT01782872 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Interscalene Block (ISB) - Systemic Control
Description: Ultrasound-guided single-injection ISB: ropivacaine 0.375%; Intravenous: clonidine (100 mcg) + dexamethasone (4 mg) + buprenorphine (150 mcg)
Study NCT05731089 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Phacoemulsification with IVI of aflibercept
Description: IVI was either before or after cataract surgery
Study NCT01403025 — intervention group
Intervention type: DRUG
Intervention: liraglutide
Description: Once daily at a fixed timing, and subcutaneously (under the skin) in the abdomen, in the thigh or in the upper arm
Study NCT02150720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic Acid
Description: 1g intra-articular before closing the wound surgery
Study NCT02150720 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Description: 5mL intra-articular before closing the wound surgery
Study NCT02150720 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrocauterization
Description: Coagulation blood from vessels by means of a electrocautery.
Study NCT02150720 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrocauterization
Description: Coagulation blood from vessels by means of a electrocautery.
Study NCT00570024 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Acupuncture
Description: In Traditional acupuncture (TA), in which eight acupuncture points are selected, subjects will undergo three 30-minute sessions weekly for 12 weeks. Disposable acupuncture needles (1-1.5 inch sterilized stainless steel)will be inserted up to one inch deep through a plastic needle tube that is secured with adhesive tape to the skin.
Study NCT00570024 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: AA
Description: In Traditional acupuncture (TA), in which eight acupuncture points are selected, subjects will undergo three 30-minute sessions weekly for 12 weeks. Disposable acupuncture needles (1-1.5 inch sterilized stainless steel)will be inserted up to one inch deep through a plastic needle tube that is secured with adhesive tape to the skin.
Study NCT03552302 — intervention group
Intervention type: BEHAVIORAL
Intervention: Yoga
Description: 1. Yoga stretch warm-up exercise for 15 minutes.~2. Five kinds of yoga correction method for 30 minutes (abdominal breathing, throat breathing, wind box breathing, nasal alternating breathing, buzzing breathing).~3. Great rest for 15 minutes
Study NCT04230057 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Antitumor B
Description: Single dose 2400 mg
Study NCT03627039 — intervention group
Intervention type: DRUG
Intervention: SGLT2
Description: All SGLT2 medications approved prior to 2017 will be included (Canagliflozin, empagliflozin, dapagliflozin (all doses, all of the medications are oral)
Study NCT03627039 — intervention group
Intervention type: DRUG
Intervention: Metformin
Description: Metformin is the main comparator of interest. In a secondary analysis GLP1 will be the comparator
Study NCT00369538 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: losartan, hydrochlorothiazide
Description: Two administrations of losartan per day,up to 100mg per day, during 2 months, followed by a wash-out during 1 month, and then one administration of hydrochlorothiazide, 25 mg per day during 2 months
Study NCT05121714 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Caffeine
Description: This is a 2 part, fixed-sequence open-label, crossover study to evaluate the potential CYP1A2-mediated drug-drug interactions (DDI), safety, and tolerability of ABX464 combined with a known CYP1A2 substrate (caffeine)
Study NCT05121714 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: ABX464
Description: This is a 2 part, fixed-sequence open-label, crossover study to evaluate the potential CYP1A2-mediated drug-drug interactions (DDI), safety, and tolerability of ABX464 combined with a known CYP1A2 inhibitor (fluvoxamine) and a known CYP1A2 substrate (caffeine).
Study NCT05121714 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Fluvoxamine
Description: his is a 2 part, fixed-sequence open-label, crossover study to evaluate the potential CYP1A2-mediated drug-drug interactions (DDI), safety, and tolerability of ABX464 combined with a known CYP1A2 inhibitor (fluvoxamine).
Study NCT01549561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Training
Description: 16 weeks of parent training led by a trained group facilitator
Study NCT01549561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Youth Skills Training
Description: 16 weeks of one-on-one sessions with a trained youth skills coach
Study NCT00565877 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ultrasound inspection
Description: post-PICC insertion Ultrasound inspection of the ipsilateral neck for PICC in a malposition (ipsilateral internal jugular vein)
Study NCT01316211 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Implantation of coflex™ after surgical decompression
Description: The device will be implanted after surgical decompression in patients with spinal stenosis.
Study NCT01316211 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical decompression
Description: Surgical decompression in patients with spinal stenosis without stabilization by an additional implant
Study NCT03174873 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: laparoscopy
Description: Laparoscopy will be done for unexplained infertile couples before starting IVF because not all pathologic lesions that discovered by laparoscope need IVF and so, protect patients from unneeded IVF program
Study NCT05287919 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Patients received the standard physical therapy (SPT) programme (passive mobilization) twice a day.
Description: All participants have received standard physical therapy (SPT) sessions based on a passive range of motion mobilization protocol for the lower limbs. It consisted of a bilateral series of 10 repetitions of hip flexion, knee flexion and extension, and ankle flexion and extension. The procedure was performed twice a day: a morning (between 8am - 12pm) and an afternoon session (between 2pm - 6pm).
Study NCT05287919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patients received the standard physical therapy (SPT) programme (passive mobilization) twice a day.
Description: All participants have received standard physical therapy (SPT) sessions based on a passive range of motion mobilization protocol for the lower limbs. It consisted of a bilateral series of 10 repetitions of hip flexion, knee flexion and extension, and ankle flexion and extension. The procedure was performed twice a day: a morning (between 8am - 12pm) and an afternoon session (between 2pm - 6pm).
Study NCT05287919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patients received the low-frequency neuromuscular electrical stimulation (NMES)
Description: Electrical stimulation was performed twice a day after SPT. Two electrodes were attached to each thigh at the motor points of the quadriceps muscle. The point halfway between the anterior superior iliac spine and the base of the patella was used as reference and electrodes were placed 15 cm apart each other, 5 cm proximal and 10 cm distal from the reference point. After the first measurement, semi-permanent markers were used to indicate the position of electrodes. Electrical stimulation was performed using a 4-channels device (Sonopuls 492, series 4, Enraf-Nonius®, Rotterdam, Netherlands). The low-frequency protocol consisted of 100 Hz and 400 ms width pulses, delivered in trains of 5 s ON (ramp-up time: 1 s, plateau: 3 s, ramp-down time: 1 s) and 10 s OFF. Sessions had 20 min of duration (total of 40 min/day) and the current amplitude (mA) was adjusted to the identification of visible and palpable contractions and was rectified every 3 min to sustain the initial level of contraction.
Study NCT05287919 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patients received the medium-frequency neuromuscular electrical stimulation (NMES)
Description: Electrical stimulation was performed twice a day after SPT. Two electrodes were attached to each thigh at the motor points of the quadriceps muscle. The point halfway between the anterior superior iliac spine and the base of the patella was used as reference and electrodes were placed 15 cm apart each other, 5 cm proximal and 10 cm distal from the reference point. After the first measurement, semi-permanent markers were used to indicate the position of electrodes. Electrical stimulation was performed using a 4-channels device (Sonopuls 492, series 4, Enraf-Nonius®, Rotterdam, Netherlands).The medium-frequency protocol had similar parameters, but a carrier frequency of 2500 Hz and burst frequency of 100 Hz. Sessions had 20 min of duration (total of 40 min/day) and the current amplitude (mA) was adjusted to the identification of visible and palpable contractions and was rectified every 3 min to sustain the initial level of contraction.
Study NCT00369538 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hydrochlorothiazide, losartan
Description: One administration of hydrochlorothiazide, 25 mg per day during 2 months, followed by a wash-out during 1 month, and then, two administrations of losartan per day,up to 100mg per day, during 2 months
Study NCT01606527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen 600mg orally three times daily
Description: Ibuprofen is taken 600mg orally three times daily
Study NCT01606527 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ibuprofen 600mg orally three times daily
Description: Ibuprofen is taken 600mg orally three times daily
Study NCT01842113 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifaximin
Description: Rifaximin 550mg by mouth twice a day
Study NCT01842113 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactulose
Description: Lactulose 30ml by mouth three times a day
Study NCT01842113 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactulose Placebo
Description: Lactulose Placebo 30ml three times a day
Study NCT01842113 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifaximin Placebo
Description: Rifaximin Placebo twice a day
Study NCT03862287 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lidocaine
Description: See arm description.
Study NCT03862287 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hcl 0.5% Inj_#2
Description: See arm description.
Study NCT01368146 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IV Clear™
Description: Polyurethane film with a silicone adhesive dressing containing chlorhexidine and silver
Study NCT01368146 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tegaderm CHG™
Description: Polyurethane film with a polyacrylate adhesive and a polyol hydrogel containing 2% w/w chlorhexidine gluconate
Study NCT01368146 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Silicone Vehicle Control Dressing
Description: Polyurethane film with silicone adhesive dressing, without antimicrobials
Study NCT04667975 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-702
Description: In principle, based on 1 cycle of 28 days (4 weeks), administer CKD-702 Inj. once every 2 weeks over 4 weeks.
Study NCT02413060 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance training
Description: This training consists 4 exercises and every exercises lasts 5 seconds.
Study NCT02413060 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Lifestyle counselling
Description: Lifestyle counselling mainly indicates dietary instruction.
Study NCT02413060 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle counselling
Description: Lifestyle counselling mainly indicates dietary instruction.
Study NCT01450748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium alginate
Description: oral suspension, 50 mg/ml, 20 ml three times daily, 8 weeks
Study NCT01450748 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: matching placebo oral suspension, 50 mg/ml, 20 ml three times daily, 8 weeks
Study NCT06103214 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: acute normovolemic hemodilution (ANH)
Description: Acute normovolemic hemodilution (ANH) is a medical procedure that involves removing a certain volume of blood from a patient before surgery and replacing it with a volume expander or blood substitute. The goal of ANH is to reduce the need for blood transfusions during or after surgery. During the ANH procedure, a patient's blood is typically withdrawn and replaced with a crystalloid or colloid solution. This dilutes the patient's blood, reducing the concentration of red blood cells. The withdrawn blood is then stored and can be reinfused back into the patient after the surgical procedure is completed.
Study NCT01068067 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: drug (tacrolimus and SchE) and genetics
Description: Patients were genotyped for the polymorphisms that can influence tacrolimus pharmacokinetics before transplantation. After transplantation, initial tacrolimus dosage was based on an algorism guided by pharmacogenetics and SchE.
Study NCT01068067 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tacrolimus
Description: After transplantation, patients received standard initial dose of tacrolimus (0.050-0.075 mg/kg).
Study NCT01382472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: 40 mg per operative in PPCI, the 40 daily during hospital stay
Study NCT06103214 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: acute hypervolemic hemodilution (AHH)
Description: The purpose of diluting the blood with fluids and removing some of the red blood cells is to decrease the viscosity of the blood. This can improve blood flow and oxygen delivery to tissues, especially in cases of decreased blood flow or oxygenation.
Study NCT02740322 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Hum Test
Description: The subject will be brought into an exam room. The subject will then be asked to hum for a few seconds in a low pitch. They will then be asked if the nose was heard more so in one ear compared to the other. The subject will then be asked to hum for a few seconds in a high pitch. They will then be asked again if the noise was heard more so in one ear compared to the other.
Study NCT02740322 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Weber Test
Description: Using a 512 Hz tuning fork, the tuning fork will be vibrated and placed on the subject's glabella (forehead landmark). The subject will then be asked if the vibration was heard more so in one ear compared to the other.
Study NCT02740322 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Audiogram
Description: A standard audiogram will be administered by an audiologist.
Study NCT04492319 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control Test
Description: spermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml 0.9 normal saline in each side
Study NCT04492319 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: spermatic cord block by 19 ml Levobupivacaine 0.5% plus 1 ml neostigmine 500 μg in each side .
Study NCT01382472 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Simvastatin
Description: No statin acutely. Simvastatin 20 mg from day 2.
Study NCT01856712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naltrexone
Description: Naltexone was chosen for this study because naltrexone is the only medication available in both oral daily and injectable monthly formulations, which will allow the study to examine issues around medication adherence.
Study NCT01856712 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Naltrexone
Description: Naltexone was chosen for this study because naltrexone is the only medication available in both oral daily and injectable monthly formulations, which will allow the study to examine issues around medication adherence.
Study NCT03607357 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High Flow Nasal Oxygen
Description: The initial flow speed is set at 30L/min and increases at 5L/min in titrated type until the patient feels uncomfortable. The temperature is set at 37℃. The fraction of inspiration O2 is set in accordance with specific condition of patient to insure oxygen saturation more than 95%.
Study NCT03607357 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Non-invasive Ventilation
Description: The values of initial pressure are set at a lower level (inspiratory pressure: 6-8cmH2O, expiratory pressure: 4cmH2O) and adjusted to a suitable level in 10-20min. The fraction of inspiration O2 is set in accordance with specific condition of patient to insure oxygen saturation more than 95%.
Study NCT03719794 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotic supplement
Description: Probiotic supplement once daily (xyz) for 12 weeks
Study NCT03719794 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo supplement
Description: Placebo supplement once daily for 12 weeks
Study NCT02541032 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intensive dental treatment
Description: Up to five sessions of full-mouth removal of subgingival dental plaque by the use of scaling and root planning under local anesthesia. Any hopeless teeth will be extracted during this treatment period, which will be as short as possible, but will extend to no more than 4 weeks. In addition to standard scaling and root planning, the investigators seek to better suppress the oral biofilm by administering Arestin locally into the periodontal pockets ≥6 mm.
Study NCT02541032 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard dental treatment
Description: Supragingival mechanical scaling and polishing.
Study NCT02541032 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Arestin
Description: To better suppress the oral biofilm by administering Arestin locally into the periodontal pockets ≥6 mm.
Study NCT01546792 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Combined lifestyle intervention
Description: Exercise training, dietary advice, behaviour change counselling
Study NCT01522534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mepivacaine
Description: mepivacaine 1% 20 ml corresponding to 200 mg
Study NCT01522534 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Morphine alone with a placebo nerve block
Study NCT03427099 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation with a biopsychosocial focus
Description: Rehabilitation with a biopsychosocial focus
Study NCT03427099 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: usual care
Study NCT04591886 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mind. body. voice.
Description: The mbv program consists of 10 weekly sessions that include a variety of practices, including: cognitive dissonance exercises, contemplative practices, guided discussion and community building.
Study NCT02048826 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FINGER I
Description: FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting I
Study NCT02048826 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FINGER II
Description: FINGER is a robot that measures finger movements and allows patients to play computer game using those movements. Patients will be exercising with FINGER using setting II
Study NCT02093455 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Chardonnay Seed Flour (CSF)
Description: CSF is made from wine grape skins and seeds.
Study NCT02093455 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT04088370 — intervention group
Intervention type: OTHER
Intervention: Blood Draw
Description: Blood Draw Only
Study NCT01180699 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza vaccine: Vaxigrip or Fluviral and Intanza
Description: Patients will be randomized to receive either one intradermal dose of 0.1 mL or one intramuscular injection of 0.5 mL of the standard influenza vaccine in the deltoid muscle of the nondominant arm.
Study NCT01180699 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Influenza vaccine: Vaxigrip or Fluviral and Intanza
Description: Patients will be randomized to receive either one intradermal dose of 0.1 mL or one intramuscular injection of 0.5 mL of the standard influenza vaccine in the deltoid muscle of the nondominant arm.
Study NCT03708640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Digital Activity Tracker
Description: Group wears physical activity tracker and receives physical activity feedback information informed by the tracker
Study NCT03708640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smart Text Messaging
Description: Group receives personalized, health coaching via smart text messages
Study NCT03708640 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical Activity Counseling
Description: Group receives baseline counseling on physical activity
Study NCT03708640 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Physical Activity Counseling
Description: Group receives baseline counseling on physical activity